Intrinsic Value of S&P & Nasdaq Contact Us

Syros Pharmaceuticals, Inc. SYRS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
35/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.67
+4762757.1%

Syros Pharmaceuticals, Inc. (SYRS) has 12 identified peers for comparison in the Healthcare sector. Peers include BDTX, BOLT, CHRS, CRNX, FIXX, GRCL and others.

SYRS has a market capitalization of $9.39K, compared to an average peer market cap of $748.73M. SYRS is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message